These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23348842)

  • 1. Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.
    Sarris J; Stough C; Teschke R; Wahid ZT; Bousman CA; Murray G; Savage KM; Mouatt P; Ng C; Schweitzer I
    Phytother Res; 2013 Nov; 27(11):1723-8. PubMed ID: 23348842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.
    Sarris J; Byrne GJ; Bousman CA; Cribb L; Savage KM; Holmes O; Murphy J; Macdonald P; Short A; Nazareth S; Jennings E; Thomas SR; Ogden E; Chamoli S; Scholey A; Stough C
    Aust N Z J Psychiatry; 2020 Mar; 54(3):288-297. PubMed ID: 31813230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of kava in the treatment of anxiety disorders.
    Singh YN; Singh NN
    CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
    Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
    Trials; 2015 Nov; 16():493. PubMed ID: 26527536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.
    Sarris J; Scholey A; Schweitzer I; Bousman C; Laporte E; Ng C; Murray G; Stough C
    Hum Psychopharmacol; 2012 May; 27(3):262-9. PubMed ID: 22311378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.
    Sarris J; Kavanagh DJ; Byrne G; Bone KM; Adams J; Deed G
    Psychopharmacology (Berl); 2009 Aug; 205(3):399-407. PubMed ID: 19430766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
    Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
    Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M; Klimm HD
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
    Volz HP; Kieser M
    Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kava in generalized anxiety disorder: three placebo-controlled trials.
    Connor KM; Payne V; Davidson JR
    Int Clin Psychopharmacol; 2006 Sep; 21(5):249-53. PubMed ID: 16877894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J; LaPorte E; Schweitzer I
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of kava (Piper methysticum) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial.
    Cribb L; Sarris J; Savage KM; Byrne GJ; Metri NJ; Scholey A; Stough C; Bousman CA
    Phytother Res; 2023 Dec; 37(12):5897-5903. PubMed ID: 37767766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.
    Boerner RJ; Sommer H; Berger W; Kuhn U; Schmidt U; Mannel M
    Phytomedicine; 2003; 10 Suppl 4():38-49. PubMed ID: 12807341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging Insights: Kava's (
    Savage K; Sarris J; Hughes M; Bousman CA; Rossell S; Scholey A; Stough C; Suo C
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm.
    Smith KK; Dharmaratne HR; Feltenstein MW; Broom SL; Roach JT; Nanayakkara NP; Khan IA; Sufka KJ
    Psychopharmacology (Berl); 2001 Apr; 155(1):86-90. PubMed ID: 11374340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled study of Kava kava in generalized anxiety disorder.
    Connor KM; Davidson JR
    Int Clin Psychopharmacol; 2002 Jul; 17(4):185-8. PubMed ID: 12131602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.
    Feltenstein MW; Lambdin LC; Ganzera M; Ranjith H; Dharmaratne W; Nanayakkara NP; Khan IA; Sufka KJ
    Phytother Res; 2003 Mar; 17(3):210-6. PubMed ID: 12672148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kava for Generalized Anxiety Disorder: A Review of Current Evidence.
    Ooi SL; Henderson P; Pak SC
    J Altern Complement Med; 2018 Aug; 24(8):770-780. PubMed ID: 29641222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.